New research and development facility opened in Cardiff

EKF Diagnostics has opened a new Research and Development (R&D) facility at its Cardiff headquarters. The new Special Projects Laboratory will focus on developing new applications for EKF’s many point-of-care and central laboratory medical products to enable the company to enter new market sectors, as well as providing additional diagnostics sales and regulatory support.

Showcasing sustainability in the laboratory: an innovative approach

Lab Innovations will showcase multiple options to help visitors future-proof their laboratories - from innovative products, to waste reduction (time included!) and sustainability. This focus is reflected in many of Lab Innovations’ key areas, including the Sustainable Laboratory zone, the Royal Society of Chemistry, Insights and Innovation, and Live Lab theatres, as well as on the stands of numerous scientific exhibitors.

G-protein-coupled receptor-specific functional antibody screening

Velabs Therapeutics has announced that its cooperation with Chiome Bioscience, Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s G-protein-coupled receptor (GPCR) target genes. The collaboration will capitalise on Velabs’ microfluidics-based technology in the field of functional antibody screening.

Applying liquid chromatography-mass spectrometry to clinical research

Thermo Fisher Scientific and Cedars-Sinai, a leading non-profit academic healthcare organisation, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications.

Telomeres: a game-changer in CLL testing

Chronic lymphocytic leukaemia (CLL) is a slowly developing blood cancer in which patients produce mutated versions of white blood cells that build up in the blood, bone marrow and lymph nodes, and crowd out healthy blood cells. It progresses at different rates in different people, and in a third of patients it never progresses at all.

Learning from history

Disce ut Proficias (Learn, that you may improve) is both the motto and guiding principle of the Institute of Biomedical Science (IBMS), and its biennial Congress embodies this ideal. Through lectures, workshops and exhibits, all that is new and relevant to the profession is brought to the delegates. So what is the relevance of the very popular History Committee exhibit that looks at the past? Some may agree with Henry Ford, who said: “History is Bunk”, others understand that knowing where we have come from deepens our understanding and insight into where we are, how we got here and why we took that route.

Sophisticated next-generation centrifugation systems

Scientists can now access a series of sophisticated next-generation centrifugation systems designed to offer improved performance, reliability, consistency and safety. These centrifugation systems are among the first to feature a full-colour, user-friendly touchscreen interface, enabling an advanced level of functionality for improved laboratory efficiencies.

Olympus camera facilitates engagement in the classroom

The WLAN-capable Olympus EP50 camera allows every microscope in a classroom to become a wireless imaging system, while also facilitating full standalone applications. The five-megapixel colour camera combines a full HD live image with fast, real-time sharing via smartphones and tablets – without the need for a PC.

Novel viruses carried by the Scottish midge discovered

Scotland’s biting midge population carries previously-unknown viruses, according to new research. The study – published in the journal Viruses and carried out by scientists at the MRC-University of Glasgow Centre for Virus Research (CVR) – used high-throughput sequencing to study, for the first time, the total collection of viruses in the biting midge (Culicoides impunctatus).

Reflecting current practice in pathology

Members of the Step Communications team responsible for the production of Pathology in Practice (PIP) will be on Stand F22 at the IBMS Biomedical Science Congress in Birmingham to discuss publishing opportunities with speakers, delegates and visitors to the exhibition.

Genomic and molecular microbiology

The next British Society for Microbial Technology (BSMT) Annual Scientific Conference will be held on Thursday, 14 May 2020 T the RAF Museum in Hendon. The conference is entitled The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

Showcasing advances shaping laboratories of the future

Lab Innovations will be a one-stop showcase of new products and various aspects involved in future-proofing the laboratory. Visitors to the NEC, Birmingham (30–31 October) will be able to discover ways to improve workflow efficiency, benefit from advances enabled by the digital age, and make sustainable procurement decisions that both support the environment and also save money.

Human IgG Kappa detection kit launched

Sphere Fluidics has introduced the Cyto-Cellect Human IgG Kappa Detection Kit, to be used in conjunction with the Cyto-Mine Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell line development.

Project Sepsis: earlier and more reliable detection

Sepsis kills five million people per year. Although it has many symptoms, they can be difficult to detect, so identifying it is very challenging. Cases can go undetected until more extreme symptoms are noticeable, by which time it is often too late to save the patient’s life.

Providing PCR-free target enrichment of single molecules

Samplix has announced the commercial launch of its Xdrop sample preparation products for polymerase chain reaction (PCR)-free target enrichment, yet maintaining PCR-level specificity. Xdrop enables single-molecule resolution and bias-free enrichment of genomic regions longer than 100 kb from as little as 1-ng genomic DNA.

Blood test to reduce late detection of lung cancer

Oncimmune, a global immunodiagnostics group, has welcomed the presentation of data by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.

MediSieve CEO receives Innovator of the Year Award

Dr George Frodsham, founder and CEO at MediSieve, the medical device company developing ‘magnetic blood filtration’, has won the Early Career Impact Award at the BBSRC Innovator of the Year Awards 2019.

Blood coagulation: an annual scientific and participants’ meeting

Over 400 delegates attended the UK NEQAS for Blood Coagulation (UK NEQAS BC) annual scientific and participants’ meeting, Clinical and Laboratory Haemostasis 2019, which was held in June at The Atrium Conference Centre, Sheffield Hallam University, Sheffield.

Lab-on-a-chip drives search for new drugs to prevent blood clots

A tiny laboratory the size of a postage stamp could be the next big thing in the search for safer anti-clotting drugs to prevent heart attacks and strokes. The effectiveness of current anti-clotting medication can be limited due to the risk of complications, driving a need for alternatives that can both prevent the formation of blood clots and reduce the risk of excessive and life-threatening bleeding.

Thousands of women to benefit from pre-eclampsia test

A new test that predicts with almost 100% accuracy that a pregnant woman will not develop pre-eclampsia within the following seven days is being fast-tracked for use across the NHS, sparing thousands of women nationwide a stressful hospital admission.